Skip to main content
2026 CRT Conference Main banner

CRT 2026

Top Abstracts

Session:: Abstracts | Endovascular | Pulmonary Embolism and Pulmonary Hypertension & Vascular Access

Facilitating Endovascular Navigation With An Active Mechatronic Guidewire: Evaluation Of The Bcv Guidewire Reveals Safety, Efficacy, And Navigability At 3 Days And At 28 Days In A Porcine Model

Sunday, March 8, 2026
11:18 AM - 11:24 AM EST
Location: Theater #2

    Speaker(s)

  • LG

    Louis-Georges Guy, PhD

    President
    Accellab Inc.
    Boisbriand, Quebec, Canada

    Disclosure(s): Accellab: Employee (Ongoing), Owner/Co-Owner Founder/Co-Founder (Ongoing); BioIntelligence: Stock-privately held company (Ongoing); EncephalX: Stock Options [in privately held companies] (Ongoing); HDAX Therapeutics: Stock-privately held company (Ongoing); NeuroServo: Stock Options [in privately held companies] (Ongoing); Puzzle Medical: Stock-privately held company (Ongoing); Spiralis Medical: Stock Options [in privately held companies] (Ongoing); Zilia: Stock Options [in privately held companies] (Ongoing)

Disclosure(s):
Louis-Georges Guy, PhD: Accellab: Employee (Ongoing), Owner/Co-Owner Founder/Co-Founder (Ongoing); BioIntelligence: Stock-privately held company (Ongoing); EncephalX: Stock Options [in privately held companies] (Ongoing); HDAX Therapeutics: Stock-privately held company (Ongoing); NeuroServo: Stock Options [in privately held companies] (Ongoing); Puzzle Medical: Stock-privately held company (Ongoing); Spiralis Medical: Stock Options [in privately held companies] (Ongoing); Zilia: Stock Options [in privately held companies] (Ongoing)